BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34068946)

  • 21. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M; Itonaga I; Iwasaki T; Tsumura H
    Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.
    Bouaoud J; Foy JP; Tortereau A; Michon L; Lavergne V; Gadot N; Boyault S; Valantin J; De Souza G; Zrounba P; Bertolus C; Bendriss-Vermare N; Saintigny P
    Oncoimmunology; 2021; 10(1):1944554. PubMed ID: 34239777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bio-Mechanical Model of Osteosarcoma Tumor Microenvironment: A Porous Media Approach.
    Hu Y; Mohammad Mirzaei N; Shahriyari L
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma.
    Jiang K; Zhang Q; Fan Y; Li J; Zhang J; Wang W; Fan J; Guo Y; Liu S; Hao D; Wang Y; Wang L; Shan L
    Cell Death Discov; 2022 Mar; 8(1):117. PubMed ID: 35292660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
    BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice.
    Mohammad Mirzaei N; Tatarova Z; Hao W; Changizi N; Asadpoure A; Zervantonakis IK; Hu Y; Chang YH; Shahriyari L
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
    Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
    Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma.
    Deng C; Xu Y; Fu J; Zhu X; Chen H; Xu H; Wang G; Song Y; Song G; Lu J; Liu R; Tang Q; Huang W; Wang J
    Cancer Sci; 2020 Jun; 111(6):1899-1909. PubMed ID: 32232912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
    Koirala P; Roth ME; Gill J; Piperdi S; Chinai JM; Geller DS; Hoang BH; Park A; Fremed MA; Zang X; Gorlick R
    Sci Rep; 2016 Jul; 6():30093. PubMed ID: 27456063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
    Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
    Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance.
    Razmara AM; Judge SJ; Gingrich AA; Cruz SM; Culp WTN; Kent MS; Rebhun RB; Canter RJ
    Front Vet Sci; 2021; 8():771737. PubMed ID: 34869744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma.
    Zhang Y; He R; Lei X; Mao L; Yin Z; Zhong X; Cao W; Zheng Q; Li D
    Front Oncol; 2022; 12():880459. PubMed ID: 35837104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model.
    Shafiekhani S; Dehghanbanadaki H; Fatemi AS; Rahbar S; Hadjati J; Jafari AH
    BMC Cancer; 2021 Nov; 21(1):1226. PubMed ID: 34781899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer.
    Shi X; Li X; Wang H; Yu Z; Zhu Y; Gao Y
    J Bone Oncol; 2019 Jun; 16():100206. PubMed ID: 31334002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.